Búsqueda de Publicación - Prisma - Unidad de Bibliometría

Publicaciones en la fuente DIGESTIVE AND LIVER DISEASE

Tipo Año Título Fuente
Resumen congreso2023Presence and severity of esophageal varices drives portal hypertension-related complications in compensated advanced nonalcoholic fatty liver diseaseDIGESTIVE AND LIVER DISEASE
Artículo2022Treatment patterns and intensification within 5 year of follow-up of the first-line anti-TNFα used for the treatment of IBD: results from the VERNE studyDIGESTIVE AND LIVER DISEASE
Resumen congreso2020Liver stiffness measurement by fibroscan predicts the occurrence of liver-related events and death in patients with NAFLD-related compensated advanced chronic liver diseaseDIGESTIVE AND LIVER DISEASE
Resumen congreso2020Obeticholic acid (OCA) improves non-invasive markers of fibrosis in patients with non-alcoholic steatohepatitis (NASH): a secondary analysis of the phase 3 regenerate studyDIGESTIVE AND LIVER DISEASE
Resumen congreso2020Obeticholic acid (OCA) improves non-invasive markers of fibrosis in patients with non-alcoholic steatohepatitis (NASH): a secondary analysis of the phase 3 Regenerate studyDIGESTIVE AND LIVER DISEASE
Resumen congreso2020The economic cost and health burden of non-alcoholic steatohepatitis in the EU5 countriesDIGESTIVE AND LIVER DISEASE
Resumen congreso2020The economic cost and health burden of non-alcoholic steatohepatitis in the EU5 countriesDIGESTIVE AND LIVER DISEASE
Resumen congreso2019Algorithms using noninvasive tests can accurately identify patients with advanced fibrosis due to NASH: data from the STELLAR clinical trialsDIGESTIVE AND LIVER DISEASE
Letter2018Clinical association of anti-glutathione S-transferase T1 antibodies and de novo immune hepatitis after hematopoietic cell transplantationDIGESTIVE AND LIVER DISEASE
Artículo2016Impaired glucose metabolism increases risk of hepatic decompensation and death in patients with compensated hepatitis C virus-related cirrhosisDIGESTIVE AND LIVER DISEASE
Artículo2015Two-week, high-dose proton pump inhibitor, moxifloxacin triple Helicobacter pylori therapy after failure of standard triple or non-bismuth quadruple treatmentsDIGESTIVE AND LIVER DISEASE
Letter2014De novo autoimmune hepatitis after interferon treatment in a liver transplant recipient with common variable immunodeficiencyDIGESTIVE AND LIVER DISEASE
Letter2011Lycium barbarum: A new hepatotoxic "natural" agent?DIGESTIVE AND LIVER DISEASE
Artículo2010Helicobacter pylori first-line treatment and rescue option containing levofloxacin in patients allergic to penicillinDIGESTIVE AND LIVER DISEASE
Artículo2007Expression of bcl-2 in ductular proliferation is related to periportal hepatic stellate cell activation and fibrosis progression in patients with autoimmune cholestasisDIGESTIVE AND LIVER DISEASE
Editorial2006Capsule endoscopy reviewed by a nurse: Is it here to stay?DIGESTIVE AND LIVER DISEASE
Artículo2001Intrahepatic hepatitis C virus replication is increased in patients with regular alcohol consumptionDIGESTIVE AND LIVER DISEASE